Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women

Nathan A. Summers; Cecile D. Lahiri; Christine D Angert; Amalia Aldredge; C. Christina Mehta; Ighovwerha Ofotokun; Anne Marie Kerchberger; Deborah Gustafson; Sheri D. Weiser; Seble Kassaye; Deborah Konkle‐Parker; Anjali Sharma; Adaora A. Adimora; Hector Bolívar; Jennifer Cocohoba; Audrey L. French; Elizabeth T. Golub; Anandi N. Sheth

doi:10.1097/qai.0000000000002447

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

INSTI use was associated with unfavorable changes in HbA1c and systolic and diastolic BP during short-term follow-up. Further research is needed to understand long-term cardiometabolic effects of INSTI use.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Summers et al. (2020) studied this question.

synapsesocial.com/papers/69dcc787a5c75be4cfe542fe https://doi.org/10.1097/qai.0000000000002447

View Full Paper

Ask AI

Bookmark

Share

Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women

Ask about this paper

Abstract

Discussion

Cite This Study

Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading